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ABSTRACT

A MICROFLUIDIC ASSAY FOR SINGLE CELL BACTERIAL ADHESION STUDIES
UNDER SHEAR STRESS

By
Amanda Trusiak
May 2022

Thesis supervised by Dr. Melikhan Tanyeri
The study of bacterial adhesion to host cells is important in understanding bacterial
pathogenesis and developing new therapeutic approaches. Here, we studied bacterial adhesion
under shear stress using a novel microfluidic method. Specifically, the adhesion of a
uropathogenic E. coli strain (FimHOn, ATCC 700928/CFT073) to mannose-modified substrates
was studied under flow conditions. The FimHOn E. coli strain expresses FimH which is a
mannose-specific adhesin found on the fimbriae that binds to glycoproteins on the epithelium.
We developed a microfluidic method that mimics bacterial adhesion to urothelial cells. First, the
microfluidic channels were modified by sequentially adsorbing BSA-mannose and BSA onto
channel surfaces. Bacterial solutions were then introduced to the microfluidic channels and
bacterial interactions with the modified surface were imaged at 5 fps for 2 minutes using phase
contrast microscopy under flow conditions. Manual tracking and TrackMate extensions of
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ImageJ were used to analyze and quantify surface adhesion of bacteria on the simulated
epithelial surface. Bacteria-surface interactions were studied with substrates modified using
8.3µg/mL, 16.7µg/mL, and 25.0µg/mL BSA-mannose solutions. Through image analysis, the
percentage of bacteria interacting with the surface and the total interaction times were
determined. The results indicated that as mannose concentration increased the average transient
adhesion time and percentage of bacteria adhered to the surface also increased. It was also
observed that bacteria permanently attached to the surface increased with time. Overall, our
results show that FimHOn E. coli specifically and transiently interacts with the mannosemodified surface. By mimicking molecular interactions and flow-induced shear stress within the
gastrointestinal, respiratory, and urogenital tracts, our microfluidic platform may help explain
mechanisms underlying bacterial infections at the mucosal epithelium. Overall, our microfluidic
approach provides a favorable platform to study bacterial host cell interactions to enable drug
discovery and testing.
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CHAPTER 1
INTRODUCTION

1.1 Bacterial Adhesion
Bacterial adhesion to the mucosal surface within the gastrointestinal, respiratory, and
urogenital tracts allow bacteria to colonize host epithelium (Martino, 2018). Adhesion is critical
in bacterial pathogenesis, occurring prior to invasion and the secretion of toxins (Letourneau et
al., 2011). Bacteria express adhesins that promote binding to receptor proteins or polysaccharides
present on epithelial cell surfaces. Adhesins are virulence factors that allow pathogenic bacteria
to specifically adhere to host cells. These adhesins are found on bacterial fimbriae, which are
subunit structures that extend from the bacterial cell surface (Schmidt et al., 2004). Fimbriae
allow for adhesion to host cells and are directly responsible for the virulence of some bacterial
pathogens (Mol et al., 1996). The FimHOn E. coli strain expresses FimH which is a mannosespecific adhesin found at the tip of the fimbriae. FimH is specifically found on type I bacterial
pili (Tuson et al., 2013). This allows the E. coli to specifically bind to mannosylated
glycoproteins on the surface of epithelial cells (Kline et al., 2009). FimH specifically binds to
glycoprotein receptors that contain monomannose and trimannose. This interaction with cellular
receptors initiates bacterial adhesion (Pizarro-Cerdá et al., 2006).
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Figure 1 Subunits of FimHOn E. coli Fimbriae: Visualization of the FimH adhesin being
expressed at the tip of the E. coli fimbriae.

The FimH adhesin has a pilin domain that anchors to the fimbriae and a lectin domain
that recognizes mannose residues on mammalian cells (Tchesnokova et al., 2011). Interactions
between bacteria and host cells are reinforced by shear stress. Catch-bonds play an important
role by permitting the capture and retention of bacteria on the epithelium under flow conditions
(Sauer et al., 2016). These catch bonds are strengthened by tensile mechanical forces
(Yakovenko et al., 2008). E. coli displays stick-and-roll adhesion where the bacterium switches
between rolling adhesion and stationary adhesion (Figure 2). The length of time bacteria
demonstrates stationary adhesion can drastically differ from milliseconds to hundreds of seconds.
2

This stick-and-roll adhesion allows for rapid colonization under ideal stress conditions (Thomas,
2008). Understanding bacterial adhesion at the single cell level will aid in overall understanding
of bacterial infections and help develop new therapeutic approaches.

Figure 2 Stick and Roll Adhesion: A visual representation of E. coli interacting with urothelial
cells utilizing stick and roll adhesion.

1.2 Urinary Tract Infection
Urinary tract infections are considered one of the most common bacterial infections, and
pathogenic E. coli strains directly contribute to the prevalence of UTIs (Flores-Mireles et al.,
2015). It is estimated that around 50-60% of women report having at least one UTI in their
lifetime. Within the United States UTIs account for 7 million office visits, 1 million emergency
department visits, and over 100,000 hospitalizations (Foxman, 2002). UTIs can affect the
3

kidneys, ureters, bladder, and urethra and have symptoms such as a burning sensation when
urinating, lower abdomen discomfort, back or side pain, high fever, nausea, and vomiting (Chu
et al., 2018). Individuals experiencing a UTI may have complications such as recurring
infections, kidney damage, urethral narrowing, and sepsis. Uropathogenic E. coli (UPEC) strains
are the most frequent pathogens responsible for UTI’s. Most pathogenic strains of E. coli exhibit
mannose-sensitive fimbriae which can attach to human urinary tract epithelial cells (Edén et al.,
1981). Among UPEC adhesion, the FimH adhesin is a major determinant of virulence (Hojati et
al., 2015). The main receptor of the FimH adhesin in the urinary tract is monomannose contained
in glycoproteins on the cell surface. This FimH interaction with bladder epithelial cells triggers a
signal transduction cascade resulting in the uptake of bacteria and chronic urinary tract infections
(Pizarro-Cerdá et al., 2006). Once E. coli attaches to the mucosal surface it can colonize and
infect the area. Understanding E. coli adhesion to human urinary tract epithelial cells is essential
to understanding UTIs and developing innovative anti-adhesive and prophylactic approaches to
prevent UTIs (Terlizzi et al., 2017).

1.3 Inflammatory Bowel Disease
A very diverse range of microbial species reside in the human intestinal tract. This
microbiota enhances the intestinal epithelial barrier and aids in the development of the immune
system (Kamada et al., 2013). Immune responses to environmental triggers can cause
inflammation within the gastrointestinal tract. It is commonly hypothesized that chronic
inflammation caused by dysbiosis in the intestinal microbiota can result in Inflammatory Bowel
Disease (IBD) (Tamboli et al., 2004). IBD is a chronic condition that encompasses Crohn’s
disease and ulcerative colitis (de Souza et al., 2016). An individual who has developed IBD can
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experience symptoms such as diarrhea, fatigue, abdominal pain, blood present in stool, and a
reduced appetite. The disease could also cause complications such as bowel obstruction due to
the thickening of the intestinal wall (Fakhoury et al., 2014). Adherent invasive E. coli (AIEC)
has been increasingly implicated in the pathogenesis of IBD. AIEC strains predominantly
express the FimH adhesin allowing them to bind to intestinal epithelial cells (Palmela et al.,
2018). This FimH expression is considered to be critical in the development of IBD (Dreux et al.,
2013). Many studies have shown that the intestinal mucosa of some IBD patients is abnormally
colonized by E. coli strains with adherent and invasive properties (Costa et al., 2020). Creating
an in vitro model of intestinal bacteria-epithelial interactions can further the general
understanding of IBD and help develop mechanism-based treatment strategies.

1.4 Methods for Studying Bacterial Adhesion at the Single Cell Level

1.4.1 Atomic Force Microscopy
Two primary methods for investigating bacterial adhesion at the single cell level are
Atomic Force Microscopy (AFM) and optical tweezers. AFM utilizes a cantilever with an
adhesin-specific coated bead attached to the tip (Gavara, 2017). Bacteria are immobilized onto a
rigid substrate such as silicon or glass. The cantilever tip is then brought into contact with the
bacterium, and the attachment force is measured by pulling upward on the bacterium until the
bond breaks (Figure 3). AFM measurements are performed without the cantilever tip touching
the surface as to avoid contamination. Scanning electron microscopy is performed on the tip of
the cantilever after the force measurement to ensure the presence of bacteria. A force curve is
recorded as the bond between the bacteria and the substrate is broken (Razatos et al., 1998). This
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enables the investigation of kinetics and strength of binding interactions between bacteria and
epithelial cells (Gavara, 2017).

Figure 3 Atomic Force Microscopy: A schematic of AFM being utilized to measure the
attachment force of a single bacterial cell to a target surface.

1.4.2 Optical Tweezers
Optical tweezers are also used to measure bacterial attachment force. With the use of an
objective lens, infrared laser beams are tightly focused to capture and manipulate an adhesin
specific coated bead. The bead is then brought into contact with bacteria. After contact is made,
optical tweezers pull the bead away until the bacterial bond breaks, thereby measuring the
attachment force (Figure 4). Optical tweezers also allow measurement of biophysical properties
of bacterial adhesion.

Figure 4 Optical Tweezers: A schematic of optical tweezers measuring the attachment force of a
single bacterial cell.
6

1.4.3 Limitations of Current Methods
Both optical tweezers and AFM provide insights into how tight the molecular adhesion
forces are between the microorganism and the host cells. However, bacterial transport and
adhesion are heavily influenced by the presence of fluid flow in microbial habitats. Cell–cell
adhesion often occurs under dynamic conditions and varying mechanical stress. As recently
described, catch-bonds also play a major role in bacterial adhesion and infection, permitting the
capture or retention of cells under flow conditions (Sauer et al., 2016). Within the intestinal tract,
luminal flow impacts adhesion to the gut epithelium and the growth of pathogenic bacteria
(Secchi et al., 2020). Therefore, it is essential to mimic the first step in the bacterial pathogenesis
in pulmonary, gastrointestinal, and urinary infections, which is the adhesion to epithelial cells
under flow conditions. While AFM and optical tweezers are useful in quantifying binding forces
and kinetics, both methods lack the ability to investigate adhesion events under shear stress
conditions. Studying bacterial adhesion under physiologically relevant conditions is essential in
explaining molecular mechanisms underlying infections.

1.5 Microfluidic Devices
Microfluidic devices enable observation of bacterial interactions under aqueous flow
conditions. For example, microfluidic devices have been used to study the effect of culture media
content on biofilm formation under the presence of fluid flow (Straub et al., 2020). Microfluidic
devices have also been used to observe the effect of shear rate on adhesion of fibroblast cells (Lu
et al., 2004). To study bacterial adhesion on mucosal surfaces, we developed a novel
microfluidic method. The microfluidic platform allows bacteria to be introduced at a constant
velocity (or shear rate) into a microchannel and adhere to the walls of the channel, thereby
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mimicking adhesion to urothelial cells. Using this platform, we studied transient interaction
times as well as the impact of surface-immobilized mannose concentration on adhesion.
Microfluidic devices allow for cost-effective, precisely controlled experiments that utilize very
small sample sizes. Microfluidic devices feature sizes that are comparable to microorganisms,
thereby providing an additional advantage to study bacterial adhesion at the single cell level.
Furthermore, microfluidic devices are disposable, which minimizes the risk of contamination for
these studies (Streets et al., 2013). A microfluidic device with straight channels was chosen for
its simplicity (Figure 5). Each microfluidic channel was 20mm long, 200µm wide and 50µm in
height. The device was composed of a PDMS slab on the top, and a glass substrate on the
bottom. The bottom glass surface of the channel allows for better imaging when observing
bacterial interactions by brightfield and phase contrast microscopy.

8

Figure 5 Microfluidic Device Design: The microfluidic design for bacterial adhesion studies.
Each individual channel had a length of 20mm, a height of 50μm, and a width of 200μm.
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CHAPTER 2
METHODS

2.1 Microfluidic Device Fabrication
Fabrication of microfluidic devices was carried out in a Class 1000 clean room using
photolithography and soft lithography techniques. The fabrication process started with a silicon
wafer to create the SU-8 mold. First, silicon wafers were cleaned with acetone and isopropyl
alcohol and dried with compressed air. The wafer was spin-coated with SU-8 2050 with a feature
height of ~50µm. The spin coating process involved three steps: a spread step at 500 rpm for 510 seconds with an acceleration of 100 rpm/second, a coating step at 2000 rpm for 30 seconds
with a ramp of 300 rpm/second, and a slowdown step at 500 rpm/second. The wafer was then
soft baked at 65°C for 3 minutes and at 95°C for 9 minutes.
The next step was photolithography where a mask containing the device features was
placed over the wafer. A quartz slab was placed on top of the mask to bring the mask in
conformal contact with the SU-8. The wafer was then exposed to UV light for 11 seconds. A
long pass filter was used to eliminate UV radiation below 350nm. After UV exposure, the wafer
was baked at 65°C for 2 minutes and at 95°C for 7 minutes. Once the baking was complete, the
image of the mask was visible in the photoresist. The wafer was immersed in a solvent-based
developer, PGMEA, and was agitated and swirled for approximately 7 minutes to fully remove
any uncross-linked SU-8. The wafer was then rinsed with isopropyl alcohol and dried with
compressed air.
After the wafer was thoroughly cleaned, it was silanized to prepare for replica molding. A
few drops of silane were added to a petri dish and placed within a vacuum desiccator with the
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silicon wafer containing the SU-8 mold. The wafer was incubated with vaporized silane under
vacuum for approximately 15 minutes. PDMS was then prepared by combining the base and the
cross-linker components at a 10:1 ratio. The PDMS was placed into a vacuum desiccator to
remove all the air bubbles from the mixture. The PDMS was then poured onto the wafer in the
petri dish and any residual bubbles were carefully removed. The wafer with the uncross-linked
PDMS layer was then placed into the oven at 75°C overnight. After the curing is complete, the
PDMS slab was removed from the wafer using a scalpel. Holes were punched into the PDMS at
the inlet and outlet of each channel using a 22-gauge needle. A glass slide was cleaned prior to
bonding using acetone and isopropyl alcohol, and the PDMS slab containing the device features
was cleaned using tape to remove any debris. The glass slide and PDMS with the device features
facing upward were placed inside a plasma chamber, and plasma was generated at a power of
30W for approximately 20 seconds. After the oxygen plasma treatment, the PDMS slab and glass
slide were brought into conformal contact to obtain an impervious seal between the two layers.
The bonded device was placed back in the oven at 75°C before use in experiments.
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Figure 6 Steps of Microfluidic Device Fabrication: A visualization of the fabrication process of
microfluidic devices utilizing photolithography and soft lithography techniques.

2.2 Bacteria Culture
The FimHOn ATCC 700928/CFT073 E. coli strain was chosen because it has been
engineered to constantly express the FimH adhesin. The expression of FimH enabled
investigation of bacteria-surface interactions for prolonged time scales. Culturing this strain of
bacteria occurred over a 2-day static incubation period. Nutrient broth (Beef extract, 3.0 g/L
Peptone, 5.00 g/L) was prepared using 8g of NB powder and 1L of DI water. The container was
agitated until the powder was completely dissolved and the mixture was sterilized through
autoclaving for 15 minutes at 121°C.
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The FimHOn ATCC 700928/CFT073 E. coli strain was cultured from glycerol stocks
stored at -80°C. Cultures were started by transferring 3μL of bacterial glycerol stock into a test
tube with 8mL of nutrient broth using standard aseptic techniques. A separate test tube
containing uninoculated media was used as a control for contamination. The cultures were
statically incubated at 37°C for 24 hours. The next day, the medium was refreshed by
transferring 800μL of cultured bacteria into a culture tube containing 7.2mL of nutrient broth.
The samples were statically incubated at 37°C for another 24 hours. After this incubation period,
bacterial cultures were diluted and used in experiments.
The bacterial concentration was determined by measuring the optical densities of the
cultures using the Eppendorf BioPhotometer. Typical optical densities for bacterial cultures
ranged between OD600 = 1.0-1.2. The cultures were diluted before loading into syringes for
microfluidic bacterial adhesion experiments. The dilution factor was determined based on the
initial bacterial concentration in the culture (based on OD measurements) and average number of
bacteria per field of view. A typical dilution factor of 20x was used for a bacterial culture with
OD600 = 1.0. We adjusted the dilution factor to ensure a sufficient number of bacterial adhesion
events during data acquisition, while avoiding overcrowding of the field of view.

2.3 Microfluidic Assays
Bacterial adhesion experiments were performed by creating a simplified microfluidic
mimic of the gut epithelium. Specifically, microchannels are functionalized with bovine serum
albumin-mannose (BSA-mannose, Carbosynth) which serves as a binding site for the bacterial
adhesin FimH. The microchannels are further treated with bovine serum albumin (BSA) to block
nonspecific interactions between the bacteria and the walls of the microchannel. The BSA
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solutions were prepared with 90μL of phosphate-buffered saline (PBS) and 5μL of 5mg/mL
BSA. BSA-mannose solutions at various concentrations (8.3µg/mL, 16.7µg/mL, and 25.0µg/mL
of BSA-mannose in PBS) were used to promote FimH specific binding to the channel surface.
The 8.3µg/mL BSA-mannose solution was prepared with 90μL of PBS, 5μL of 5mg/mL BSA
solution, and 5μL of 2.5μM BSA-mannose solution. Similarly, 16.7µg/mL and 25.0µg/mL BSAmannose solutions were prepared by adding 10μL and 15µL of 2.5μM BSA-mannose solution
into 5μL of 5 mg/mL BSA solution and 85μL and 80µL of PBS, respectively. FimHOn E. coli
was prepared at a 20x dilution with nutrient broth by diluting 50μL of cultured bacteria into
950μL of nutrient broth for experiments.

2.4 Agglutination Assay
Agglutination tests were performed to confirm expression of FimH. The expression of
bacterial adhesins is often validated by the ability of the bacteria to agglutinate yeast cells
(Figure 7, left panel). Both adherence and agglutination entail expression of bacterial pili (Eshdat
et al., 1981). Here, we performed a yeast agglutination assay to demonstrate expression of
bacterial adhesins by the E. coli strain used in the experiments. Yeast is used because the cell
surface glycans contain mannose, a target for the FimH adhesin. First, a 0.1% yeast stock
solution was prepared by adding 0.01g of yeast into 10mL of PBS. The mixture was gently
shaken until the yeast dissolved. The yeast solution was incubated in a water bath at 37°C for 20
minutes to activate and release yeast cells. After blooming, the tube was gently agitated again to
ensure all live yeast cells had been uniformly dispersed into the solution.
A 1% crystal violet stock solution was prepared by dissolving 0.1g of crystal violet into
10mL of PBS to stain bacteria and yeast cells. Furthermore, 1mL of cultured bacteria was
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centrifuged for 5 minutes at 5000rpm. The supernatant was gently removed, and the bacterial
pellet was resuspended in 200μL of PBS. This washing steps was repeated 3 times to ensure
complete removal of bacterial growth medium. Furthermore, 2.5mL of yeast stock solution and
50μL of the crystal violet stock solution were pipetted into 15mL falcon tubes.
For the agglutination assay, bacterial solution in PBS was serially diluted (2x) along the
rows of a 96 well plate such that each well contains 50µL of the sample. Next, 150µL of crystal
violet stained yeast solution was added to each well. After a 5-minute incubation period, the
agglutination of yeast by mannose-specific bacterial lectins (FimH) was examined under the
microscope at 4x magnification. We observed that the statically cultured FimHOn ATCC
700928/CFT073 E. coli strain resulted in yeast agglutination, suggesting expression of the FimH
adhesin. As a control experiment, we conducted agglutination experiments where we added a
mannose substitute, methyl α-D-mannopyranoside, to each well. In the presence of excess
methyl α-D-mannopyranoside, bacterial adhesins were occupied, thereby hindering their ability
to agglutinate yeast cells (Figure 7, right panel). We observed that yeast agglutination of
FimHOn E. coli was inhibited by the addition of excess methyl α-D-mannopyranoside, further
confirming that agglutination was due to mannose-specific FimH binding.
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Figure 7 Agglutination Assay: Yeast cells are clumped together by E. coli adhesion in the
coagulation experiment (left), while Methyl α-D-mannopyranoside prevents adhesion and
clumping (right).

2.5 Experimental Procedure
The experimental setup consisted of a microfluidic device, a syringe pump (Harvard
Apparatus Pump 11 Elite, 70-4505), an inverted research microscope (Nikon Ti2-E) equipped
with 20x and 40x phase contrast objective lenses, and a CCD camera (Basler acA1920-155um)
(Figure 8 and 9).
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Figure 8 Schematic of the Experimental Setup: Experiments consisted of bacteria flowing
through the microfluidic device at a constant velocity while monitoring adhesion to the simulated
gut epithelial surface. Phase contrast microscopy was used to capture images of bacteria
interacting with the microfluidic surface.
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A

B

Figure 9 Image of the Experimental Setup: (A) The syringe pump was used to introduce bacteria
into the microfluidic device at a constant flow rate. Bacterial interactions were then captured
using the microscope equipped with a CCD camera. (B) A closeup view of the microfluidic
device mounted on the microscope stage. Tubing was connected to the inlet and outlet of the
device channel allowing bacteria to flow through.
18

Bacterial solutions were introduced into a microchannel functionalized with BSAmannose, and the interaction of the bacteria with the surface was imaged using phase contrast
microscopy. For the bacterial adhesion experiments, the microchannels within the microfluidic
device were modified with BSA and BSA-mannose (Figure 10). First, 10μL of PBS was flown
into the microchannel. The channel was then flushed with either 10μL of the BSA solution or
10μL of one of the BSA-mannose solutions. The device was then incubated at room temperature
for 10 minutes to enable adsorption of proteins to microchannel surfaces. After the incubation
period was complete, the channel was flushed with 10μL of PBS to remove excess protein from
the microchannel. While the BSA-mannose assays promoted bacterial adhesion to the surface, a
BSA-only assay was carried out as a control experiment.

Figure 10 Adsorption of BSA and BSA-Mannose to Microfluidic Device Surfaces: A
visualization of BSA and BSA-mannose being adsorbed onto the microfluidic device surface.

A 1 mL syringe (SGE 1MDF-LL-GT) was loaded with a 20x bacteria dilution, and all air
bubbles were removed. To sterilize the syringe and prevent contamination prior to loading, the
syringe was initially flushed with 1000μL of ethanol with the tubing attached. The syringe and
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tubing were then flushed with 1000μL of PBS three times to thoroughly rinse out any trace of
ethanol. The syringe was mounted on the syringe pump and set up to run at 100μL/hr to prime
the microfluidic channel and eliminate any air bubbles to ensure consistent flow. The syringe
pump was then slowed down to 20μL/hr, and the outlet tubing was inserted into an Eppendorf
tube to collect the waste . Next, the flow rate was further reduced to 5μL/hr. Bacterial adhesion
events were imaged at the bottom surface of the microchannel at 60x magnification (40x lens
with additional 1.5x magnification) using phase contrast microscopy (Figure 11).

Figure 11 Mannose-Specific Adhesion Between E. coli and the BSA-Mannose Modified Surface:
A schematic of the FimH adhesin located on the pili of the E. coli specifically binding to BSAmannose immobilized on the microfluidic device surface.
20

Bacterial interactions with the surface, including transient and permanent binding events,
were captured in real-time using a CCD camera (Basler acA1920-155um) mounted on the
microscope. As the bacteria flowed through the channel and interacted with the surfaceimmobilized mannose, we captured 600 images (1920x1200 pixels) at 5 frames per second for a
total of 2 minutes. Several image sets were obtained to ensure observation of numerous surface
binding events.

2.6 Image Processing
Images captured in experiments were processed using ImageJ. First, images were
converted into a stack. The magnification factor and pixel size (5.86 µm) were used to calculate
the correct length scale on the images. Plugins such as TrackMate and Manual Tracking were
then used to track bacterial trajectories along the microchannel and quantify bacterial interactions
(Figure 12). TrackMate was used to track all bacteria within the field of view (and in focus)
simultaneously (Tinevez et al., 2017). The images were binarized by determining an intensity
threshold. Careful selection of the threshold enables tracking of most bacteria within the field of
view. Erroneous trajectories were manually removed from the data. Upon quality control,
bacterial interactions were quantified by determining the number of bacteria interacting with the
surface as well as the duration of the interaction.
The Manual Tracking plugin was used to improve data accuracy on transiently interacting
bacterium. Images were analyzed to identify and locate bacteria that briefly adhered to the
surface. Detected trajectories were further examined manually frame by frame to ensure
accuracy in interaction times and measurement of positions and displacement.
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B

A

Figure 12 Tracking Bacterial Interactions Using Image Processing Tools: (A) Bacterial
interactions were analyzed using the TrackMate plugin of ImageJ tracking all bacteria within the
field of view (highlighted) simultaneously. (B) The trajectory of each transiently interacting
bacterium was inspected manually to ensure accuracy.
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CHAPTER 3
RESULTS

3.1 Optical Density Results
Optical densities of the nutrient broth control and cultured bacteria solution were
observed to quantify bacteria in each culture and determine a dilution factor for the bacterial
adhesion experiments. The average optical density of the nutrient broth control was 0.0008 ±
0.0015, and the average optical density of the cultured bacteria was 1.10 ± 0.04. The average
optical density readings were consistent throughout all experiments.

3.2 Agglutination Results
A

B

Figure 13 FimHOn Yeast Agglutination Results: (A) The control experiment in the presence of
bacteria but not the FimH inhibitor shows the yeast cells noticeably clumping together. (B) The
experiment with the FimH inhibitor, Methyl α-D-mannopyranoside, shows the yeast cells
uniformly distributed, and not forming clumps.
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To test the expression of FimH we conducted yeast agglutination assays with FimHOn E.
coli. We anticipated that bacteria expressing FimH will exhibit mannose-sensitive yeast cell
agglutination (Mirelman et al., 1980). We observed that the assay with FimHOn E. coli resulted
in clumping of the yeast (Saccharomyces cerevisiae) cells by bacteria (Figure 13A).
Furthermore, the assay with FimHOn E. coli in the presence of methyl α-D-mannopyranoside
resulted in suppression of agglutination of yeast cells (Figure 13B). A control experiment with
wild-type E. coli was also conducted and yielded minimal agglutination, further suggesting that
the FimHOn E. coli was specifically binding to yeast cells (Firon et al., 1984). As a result, we
conclude that the FimHOn E. coli strain expresses FimH and yields a mannose-specific
agglutination of yeast cells.

3.3 Bacterial Interaction Types
To investigate bacterial adhesion to surfaces mimicking urothelium and gut epithelium,
we observed the interaction of FimHOn E. coli strains with mannose modified microfluidic
channels. Due to the shear dependent stick-and-roll adhesion of type I fimbriated E. coli with the
surface (Thomas et al., 2004), we specifically observed bacteria that flow along and interact with
the bottom surface of the microfluidic channel. While some bacteria did not interact with the
surface (Figure 14A), others interacted for short (Figure 14B) and long (Figure 14C) durations,
or were permanently attached to the surface (Figure 14D).
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Figure 14 Bacterial Interactions with Mannose Modified Microchannel Surface: Sample
bacterial traces for: (A) Non-interacting bacteria flowing at a constant velocity through the
microchannel, (B) Bacteria exhibiting short transient interaction with the surface and continuing
to flow through the device, (C) Bacteria exhibiting long transient interaction before detaching
and continuing to flow through the device, and (D) Bacteria permanently adhered to the channel
surface. Each plot represents the position of the bacteria along the channel length (and along the
direction of the flow) as a function of time.
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Figure 15 Distribution of Transient Interaction Times Under Varying Concentrations of Surface
Immobilized Mannose: Time histograms of transiently interacting bacteria for 8.3µg/mL,
16.7µg/mL, and 25.0µg/mL of BSA-mannose treatment.
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Figure 16 Analysis of Bacterial Interaction with the BSA-modified Microchannel Surfaces: A
positive correlation was observed between: (A) BSA-mannose concentration and the average
transient interaction time of bacteria with the device surface, (B) BSA-mannose concentration
and the average number of bacteria transiently interacting with the microchannel surface, (C)
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BSA-mannose concentration and the number of bacteria adhered to the microchannel surface,
and (D) BSA-mannose concentration and the percentage of bacteria adhered to the device
surface. (E) As time increased, the percentage of bacteria permanently adhered to the surface
also increased.

3.4 Bacterial Adhesion Results
Bacterial adhesion was observed using microchannels with no BSA-mannose, or
functionalized with 8.3µg/mL, 16.7µg/mL, or 25.0µg/mL BSA-mannose solutions. Results
indicated that as BSA-mannose concentration increased, the average transient interaction time
and the average number of bacteria adhered to the surface also increased (Figure 16). It was also
observed that the percentage of permanently adhered bacteria increased overtime across three
experimental conditions. Regarding the transient interaction times, the results of a one-way
ANOVA indicated a significant difference between the control and mannose-modified
microchannels with a significance score of 0.05 (F(3,112) = 3.745, p = 2.7). This suggests that
the interaction between the bacteria and the modified surface was mannose-specific.
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CHAPTER 4
DISCUSSION AND FUTURE WORK

4.1 Discussion
In this study, we demonstrated a microfluidic platform mimicking bacterial adhesion to
epithelial surfaces to potentially allow for a better understanding of pathogenesis at the mucosal
level. Specifically, we cultured an engineered E. coli strain that consistently expresses the Type I
fimbrial adhesin, FimH. Through agglutination testing, we confirmed mannose-specific
clustering of yeast cells by the engineered bacterial strain. A FimH antagonist, mannoside,
effectively inhibited agglutination, which indicates the expression of fimbrial lectin. A control
experiment with the wild-type strain yielded minimal agglutination, further suggesting that the
bacteria were interacting with the yeast through mannose-specific binding. We conclude that the
FimHOn strain is expressing the FimH adhesin allowing for mannose-specific interactions.
We observed that the E. coli transiently interacted with the mannose-modified surface in
a stick-and-roll manner. Bacterial interaction times varied; we observed both short and long
adhesion events at the microchannel surface. The mean transient interaction time and the number
of bacteria adhered to the surface increased with surface-bound BSA-mannose concentration,
indicating mannose-lectin specific binding events at the microchannel surface. We conclude that
FimHOn E. coli specifically and transiently interacts with the mannose-modified surface.
We also observed that the percentage of permanently adhered bacteria increased as time
elapsed, indicating that while the majority of interactions were specific, a small portion of the
bacterial population interacted with the surface in a non-specific manner. A small proportion of
transient bacterial adhesions can last for longer durations of time, such as tens to hundreds of
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seconds. This suggests that longer observation times may be required to accurately distinguish
between prolonged specific and non-specific interactions.

4.2 Future Work
While this study demonstrates mannose-specific interaction of type I fimbriated E. coli, it
would be important to investigate the effect of shear rate on bacterial adhesion by modifying the
flow rate of the bacterial solution. Potential correlations can be observed between shear rate and
average transient interaction time with the modified surface. Future work can also include testing
the effect of inhibitors such as D-mannose and binding pocket mutations on the average transient
interaction time with the surface. D-mannose in free solution is thought to prevent E. coli from
binding to the epithelium, thus preventing bacterial infection (Ala-Jaakkola et al., 2022). The
microfluidic platform can be used to observe transient interactions in the presence of various
inhibitors. For example, the FimH blocker, TAK-018 inhibits bacterial adhesion to the intestinal
epithelium, thereby potentially preventing bowel inflammation (Chevalier et al., 2021).
Similarly, a high-affinity FimH inhibitor, M4284, has been shown to reduce bacterial
colonization while simultaneously treating urinary tract infections (Spaulding et al., 2017).
Testing of such inhibitors could potentially improve our understanding of UTI and IBD
pathogenesis and help develop therapeutic approaches.

4.3 Conclusion
Overall, by mimicking molecular interactions and flow-induced shear stress, our
microfluidic platform was capable of emulating FimH specific adhesion to mannosylated
glycoproteins on mucosal surfaces. Both transient interaction time and the number of bacteria
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transiently interacting with the surface increased as a function of surface immobilized mannose
concentration. Extensive in vitro studies of bacterial-surface interactions within microfluidic
platforms can enable future drug discovery and testing of pathogenic E. coli strains, and may
help explain mechanisms underlying bacterial infections at the mucosal epithelium.
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